Invizius Receives MHRA Approval to Commence First-in-Human C

/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and...

Related Keywords

Glasgow , Glasgow City , United Kingdom , Edinburgh , City Of , Manchester , Scotland , Richard Boyd , Jonathan Milner , Duha Ilyas , Karolinska Institutet , Sandip Mitra , Leonard Ebah , Candy Herbert , University Of Manchester , Manchester University Hospitals , University Of Heidelberg , Prnewswire Invizius Limited , Regulatory Agency , Foundation Trust , University Of Oxford , University Medical Centre Groningen , University Medical Centre Groningen Netherlands , University Of Strathclyde , Edinburgh University Old College Capital , United Kingdom Medicines , Professor Sandip Mitra , Co Investigators Dr Leonard Ebah , Angry Blood , Chief Executive Officer , Chief Technology Officer , Key Opinion Leaders , Scottish Enterprise , Complement Activation Precedes , Cardiovascular Events , Invizius ,